Clinical Trials Directory

Trials / Completed

CompletedNCT01090609

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Multicenter, Prospective, Non-randomized Study to Evaluate the Safety of Cronus® Cobalt Chromium Coronary Stent - Study After 9 Months

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
263 (actual)
Sponsor
Scitech Produtos Medicos SA · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The objective this study is evaluate the performance and safety of Chronus® cobalt-chromium coronary stent in patients with "de novo" native coronary artery lesions treated with 19-mm-long stents in long-term 9 months.

Detailed description

The use of coronary stents has optimized the results of coronary balloon angioplasty for two reasons: 1. reduced acute complications, such as acute and subacute occlusion, as well as the need of urgent myocardial revascularization; 2. reduced coronary restenosis. STRESS and BENESTENT 1 pivotal clinical trials7,9 laid the foundations for approval and confirmation of the efficacy of coronary stents. These studies showed a reduction in the binary angiographic restenosis rates from 42.1% to 31.6% (p\<0.05) and from 32% to 22% (p=0.02), respectively. The efficacy of coronary stents is due to the fact that these devices reduce the acute elastic recoil and late negative remodeling of coronary arteries because of their capacity to maintain the vessel adequately open without reducing vessel diameter. Cronus® stent is fabricated in cobalt-chromium. This alloy is currently used cardiovascular stents and permanent implants in orthopedic (hips, knees), dental and maxillofacial surgeries. Guidant and Medtronic have conducted clinical evaluations of stents fabricated with a similar cobalt-chromium alloy and demonstrated safety and efficacy of the investigational devices. Both stents are currently available in the European market.

Conditions

Interventions

TypeNameDescription
DEVICEStent implantationStent implantation

Timeline

Start date
2010-05-01
Primary completion
2012-09-01
Completion
2014-11-01
First posted
2010-03-22
Last updated
2014-11-14

Locations

13 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01090609. Inclusion in this directory is not an endorsement.